Pharmaceutical Executive Daily: WeightWatchers Planning to Offer Wegovy Following Approval
In today’s Pharmaceutical Executive Daily, WeightWatchers plans to offer Novo Nordisk’s oral Wegovy pending FDA approval, FDA unveils a new Plausible Mechanism Pathway to accelerate drug reviews, and Ovid Therapeutics and Metagenomi share key third-quarter results and leadership changes.
--------
1:39
--------
1:39
Pharmaceutical Executive Daily: Dr. Richard Pazdur Appointed as Director CDER
In today’s Pharmaceutical Executive Daily, Richard Pazdur is named director of FDA’s Center for Drug Evaluation and Research, Pfizer strengthens focus through strategic partnerships and spin-offs, and CMS launches a new initiative to reduce Medicaid drug costs.
--------
2:05
--------
2:05
Pharmaceutical Executive Daily: AstraZeneca Becomes UK's Largest Stock
In today’s Pharmaceutical Executive Daily, AstraZeneca surpasses Shell to become the UK’s largest listed company, Basel intensifies efforts to attract international pharma executives, and HHS removes misleading safety warnings from menopausal hormone therapy labels.
--------
2:08
--------
2:08
Pharmaceutical Executive Daily: Wegovy Shows Potential to Treat MASH Patients
--------
2:11
--------
2:11
Raising Biomarker Awareness
Dr. Jaspal Singh explains some of the barriers that prevent cancer patients from getting biomarker testing early in their treatment journey.
The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and PharmExec.com to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry.
Brasil